Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials!!

Clinical Trial 471

Winter Park, FL 32789

Study Summary:

Randomized, stratified, double blind, placebo controlled, phase II study of the steroid sparing properties of Sagramostim (Leukine) therapy in patients with corticosteroid dependent Crohn's Disease.

Qualified Participants Must:

• have active corticosteroid dependent Crohn's Disease
• be receiving 10-40 mg of prednisone daily, for more than 3 months, with one documented unsuccessful attempt to taper
• have CDAI score of 151-450
• Not have had GI surgery within previous 6 months.

Qualified Participants May Receive:


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.